Drug Shortage Report for TEVA-BUDESONIDE
| Report ID | 107964 |
| Drug Identification Number | 02465949 |
| Brand name | TEVA-BUDESONIDE |
| Common or Proper name | BUDESONIDE INH 0.125MG/ML 2ML |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 0.125MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INHALATION |
| Packaging size | 20 |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-03-04 |
| Estimated end date | 2020-03-31 |
| Actual end date | 2020-03-18 |
| Shortage status | Resolved |
| Updated date | 2020-03-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-03-19 | French | Compare |
| v3 | 2020-03-19 | English | Compare |
| v2 | 2020-03-06 | French | Compare |
| v1 | 2020-03-06 | English | Compare |
Showing 1 to 4 of 4